Trial Profile
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Eye disorders; Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- Sponsors Allergan
- 13 Nov 2014 New trial record